Stock Events

Stock Events

Pacific Biosciences of California 

€1.3
379
-€0-0.04% Tuesday 19:17

Statistics

Day High
1.32
Day Low
1.3
52W High
2.25
52W Low
0.81
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.12
-0.12
-0.11
-0.11
Expected EPS
-0.12089720112999999
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow P09.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.63B
Illumina offers sequencing and array-based solutions for genetic and genomic analysis, directly competing in the DNA sequencing market with PACB.
Bionano Genomics
BNGO
Mkt Cap13.09M
Bionano Genomics provides optical genome mapping solutions, which compete with PACB's long-read sequencing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific offers a range of sequencing and genetic analysis products, competing in the broader genomics space with PACB.
Qiagen NV
QGEN
Mkt Cap7.06B
Qiagen offers sample to insight solutions including sequencing technologies that compete with PACB's offerings.
Intellia Therapeutics
NTLA
Mkt Cap1.58B
Intellia Therapeutics is involved in CRISPR gene editing, a field that relies on accurate DNA sequencing, where PACB's technologies are used.
Editas Medicine
EDIT
Mkt Cap283.93M
Editas Medicine operates in the genome editing space, competing indirectly by relying on sequencing technologies similar to those offered by PACB for its gene editing projects.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is engaged in gene-based medicine, depending on sequencing technologies where PACB's long-read capabilities are beneficial.
Agenus
AGEN
Mkt Cap147.45M
Agenus is involved in immuno-oncology, a field that increasingly relies on genomic sequencing for personalized medicine, indirectly competing with PACB.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health focuses on liquid biopsies and cancer diagnostics, using sequencing technologies that compete with PACB's offerings in the genomic analysis market.

About

There is no Profile data available for P09.SG.
Show more...
CEO
Country
United States
ISIN
US69404D1081

Listings

MX
MX
PACB.MX
MU
DE
P09.MU
STU
DE
P09.STU
F
DE
P09.F

0 Comments

Share your thoughts

FAQ

What is Pacific Biosciences of California stock price today?▼
The current price of P09.STU is €1.3 EUR — it has decreased by -0.04% in the past 24 hours. Watch Pacific Biosciences of California stock price performance more closely on the chart.
What is Pacific Biosciences of California stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pacific Biosciences of California stocks are traded under the ticker P09.STU.
Is Pacific Biosciences of California stock price growing?▼
P09.STU stock has risen by +5.03% compared to the previous week, the month change is a +14.11% rise, over the last year Pacific Biosciences of California has showed a +35.87% increase.
When is the next Pacific Biosciences of California earnings date?▼
Pacific Biosciences of California is going to release the next earnings report on May 07, 2026.
What were Pacific Biosciences of California earnings last quarter?▼
P09.STU earnings for the last quarter are -0.11 EUR per share, whereas the estimation was -0.12 EUR resulting in a +9.53% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Pacific Biosciences of California located?▼
Pacific Biosciences of California operates in the Materials sector.
When did Pacific Biosciences of California complete a stock split?▼
Pacific Biosciences of California has not had any recent stock splits.